Thermo Fisher Scientific Inc.
605.69USD
+2.6700 (+0.44%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $6.4▲ | $6.37 | 13 | 6 |
| Next quarter | $7.28▼ | $7.34 | 5 | 15 |
| Current year | $25.13▲ | $24.86 | 24 | 0 |
| Next year | $27.53▲ | $27.26 | 22 | 2 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $5.71 | $6.03 | +0.32 (+5.6%) |
| 2026-03-31 | $5.24 | $5.44 | +0.20 (+3.8%) |
| 2025-12-31 | $6.45 | $6.57 | +0.12 (+1.9%) |
| 2025-09-30 | $5.5 | $5.79 | +0.29 (+5.3%) |
375 ratings from 44 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| CLSA | Initiated | Outperform | $748 | Sep 3, 2026 |
| Piper Sandler | Maintained | Neutral | $510 $600 | Jul 27, 2026 |
| Morgan Stanley | Maintained | Overweight | $620 $650 | Jul 27, 2026 |
| RBC Capital | Maintained | Sector Perform | $490 $580 | Jul 24, 2026 |
| Barclays | Maintained | Overweight | $625 $650 | Jul 24, 2026 |
| Evercore ISI Group | Maintained | Outperform | $575 $570 | Jul 6, 2026 |
| Piper Sandler | Initiated | Neutral | $510 | Jun 11, 2026 |
| HSBC | Downgraded from Buy | Hold | $670 $540 | Jun 3, 2026 |
| Wells Fargo | Maintained | Overweight | $675 $615 | May 8, 2026 |
| Stifel | Maintained | Buy | $700 $600 | Apr 24, 2026 |
| Baird | Maintained | Outperform | $653 $639 | Apr 24, 2026 |
| Barclays | Maintained | Overweight | $650 $625 | Apr 14, 2026 |
| Evercore ISI Group | Maintained | Outperform | $650 $575 | Apr 6, 2026 |
| Citigroup | Maintained | Buy | $660 $685 | Jan 30, 2026 |
| TD Cowen | Maintained | Buy | $696 $683 | Jan 30, 2026 |
| Barclays | Maintained | Overweight | $625 $650 | Jan 30, 2026 |
| Stifel | Maintained | Buy | $583 $700 | Jan 9, 2026 |
| TD Cowen | Maintained | Buy | $654 $696 | Jan 7, 2026 |
| Wells Fargo | Maintained | Overweight | $635 $675 | Dec 15, 2025 |
| Citigroup | Upgraded from Neutral | Buy | $580 $660 | Dec 11, 2025 |
| Goldman Sachs | Initiated | Buy | $685 | Dec 9, 2025 |
| Keybanc | Upgraded from Sector Weight | Overweight | $750 | Dec 8, 2025 |
| Morgan Stanley | Maintained | Overweight | $656 $670 | Dec 2, 2025 |
| HSBC | Upgraded from Hold | Buy | $550 $670 | Dec 1, 2025 |
| Argus Research | Maintained | Buy | $580 $610 | Oct 29, 2025 |
155 filings from 27 insiders · 20 buy / 13 sell over 6m
Officers and directors of TMO, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Pettiti GianlucaOfficer, President & COO | ExerciseStock Option (Right to Buy) | 3.7k | — | — | Aug 31, 2026 |
| Pettiti GianlucaOfficer, President & COO | Sell | 3.7k | $614.38 | $2.29M | Aug 31, 2026 |
| Pettiti GianlucaOfficer, President & COO | Exercise | 3.7k | $309.63 | $1.16M | Aug 31, 2026 |
| Pettiti GianlucaOfficer, President & COO | Sell | 400 | $614.38 | $246k | Aug 31, 2026 |
| CASPER MARC NDirector; Officer, Chairman & CEO | Tax | 531.851 | $622.18 | $331k | Aug 28, 2026 |
| CASPER MARC NDirector; Officer, Chairman & CEO | Tax | 724.766 | $622.18 | $451k | Aug 28, 2026 |
| Meyer JamesOfficer, Sr. Vice President & CFO | Tax | 113.623 | $622.18 | $71k | Aug 28, 2026 |
| Meyer JamesOfficer, Sr. Vice President & CFO | Tax | 55.12 | $622.18 | $34k | Aug 28, 2026 |
| Meyer JamesOfficer, Sr. Vice President & CFO | Tax | 19.824 | $622.18 | $12k | Aug 28, 2026 |
| Meyer JamesOfficer, Sr. Vice President & CFO | Tax | 44.483 | $622.18 | $28k | Aug 28, 2026 |
| Meyer JamesOfficer, Sr. Vice President & CFO | Tax | 37.23 | $622.18 | $23k | Aug 28, 2026 |
| Shropshire Thomas B Jr.Officer, SVP and General Counsel | Tax | 49.024 | $622.18 | $31k | Aug 28, 2026 |
| Shafer Michael DOfficer, Executive Vice President | Tax | 227.245 | $622.18 | $141k | Aug 28, 2026 |
| Shafer Michael DOfficer, Executive Vice President | Tax | 189.533 | $622.18 | $118k | Aug 28, 2026 |
| Shafer Michael DOfficer, Executive Vice President | Tax | 210.806 | $622.18 | $131k | Aug 28, 2026 |
| Shafer Michael DOfficer, Executive Vice President | Tax | 162.457 | $622.18 | $101k | Aug 28, 2026 |
| Holmes Joseph R.Officer, VP & Chief Accounting Officer | Tax | 14.97 | $622.18 | $9k | Aug 28, 2026 |
| Holmes Joseph R.Officer, VP & Chief Accounting Officer | Tax | 11.447 | $622.18 | $7k | Aug 28, 2026 |
| Holmes Joseph R.Officer, VP & Chief Accounting Officer | Tax | 12.915 | $622.18 | $8k | Aug 28, 2026 |
| Holmes Joseph R.Officer, VP & Chief Accounting Officer | Tax | 10.567 | $622.18 | $7k | Aug 28, 2026 |
No analyst notes on TMO yet.
Analyst Ratings
27 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 4 | 19 | 5 | 0 | 1 | Buy2.14 |
| 1 mo ago | 3 | 19 | 5 | 0 | 1 | Buy2.18 |
| 2 mo ago | 3 | 19 | 6 | 0 | 0 | Buy2.11 |
| 3 mo ago | 5 | 18 | 6 | 0 | 0 | Buy2.03 |